Found 2 hits in this display Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Neuropeptide Y receptor type 2
(Homo sapiens (Human)) | BDBM50352390
(CHEMBL1823575)Show SMILES CCC(CC)C(=O)Nc1ccc(N2CCN(CC2)C(C(=O)N(CC)CC)c2ccccc2)c(c1)C#N Show InChI InChI=1S/C29H39N5O2/c1-5-22(6-2)28(35)31-25-14-15-26(24(20-25)21-30)33-16-18-34(19-17-33)27(23-12-10-9-11-13-23)29(36)32(7-3)8-4/h9-15,20,22,27H,5-8,16-19H2,1-4H3,(H,31,35) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting |
Bioorg Med Chem Lett 21: 5552-6 (2011)
Article DOI: 10.1016/j.bmcl.2011.06.136 BindingDB Entry DOI: 10.7270/Q2R49R5K |
More data for this Ligand-Target Pair | |
Neuropeptide Y receptor type 2
(Homo sapiens (Human)) | BDBM50352390
(CHEMBL1823575)Show SMILES CCC(CC)C(=O)Nc1ccc(N2CCN(CC2)C(C(=O)N(CC)CC)c2ccccc2)c(c1)C#N Show InChI InChI=1S/C29H39N5O2/c1-5-22(6-2)28(35)31-25-14-15-26(24(20-25)21-30)33-16-18-34(19-17-33)27(23-12-10-9-11-13-23)29(36)32(7-3)8-4/h9-15,20,22,27H,5-8,16-19H2,1-4H3,(H,31,35) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting |
Bioorg Med Chem Lett 21: 5552-6 (2011)
Article DOI: 10.1016/j.bmcl.2011.06.136 BindingDB Entry DOI: 10.7270/Q2R49R5K |
More data for this Ligand-Target Pair | |